Wikidata

(Q63339152)

English

Carboplatin and Bevacizumab for Recurrent Ependymoma

clinical trial

In more languages

Statements

title
Phase II Trial of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma in Adults: A Multi-Center Trial (English)
0 references
start time
3 December 2015
0 references
end time
1 July 2019
0 references
number of participants
46
0 references
research intervention
bevacizumab
0 references
carboplatin
0 references
minimum age
18 year
0 references
maximum age
99 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63339152&oldid=1857172792"